Pitavastatin study for patients on this statin
Part of Hormones & metabolism clinical trials.
This study collects information from patients who are already taking pitavastatin, a cholesterol-lowering medication, as recommended by Polish guidelines. The goal is to learn more about how it works in real-world use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently taking pitavastatin.
- Your doctor prescribed pitavastatin based on Polish cholesterol guidelines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This study follows people who are already taking PCSK9 inhibitor shots to see how well patients stay on treatment and how effective it is. Your participation would mainly be about consenting to provide basic information and possibly follow-up details.
This study tests a new injectable medication called HST101 for lowering cholesterol in people who are already taking cholesterol pills but still have high levels. It may help if you have heart disease or are at high risk.
This study tests a new drug, HST101, to see if it is safe for healthy Chinese people with high cholesterol. It is an early-phase trial, so it focuses on safety first.
This study looks at using a genetic test to help doctors choose the best statin medicine for veterans who need to lower their cholesterol but haven't taken a statin in the last 6 months. If you have diabetes, heart disease, or have had a stroke, this trial may help find a statin that works well for you with fewer side effects.
This trial tests a new medicine, Artisterol, to see if it can lower cholesterol in people with mildly high levels. It may be an option if you haven't tried other treatments or can't take statins.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.